Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Orion Pharma (UK) Limited
Oaklea Court, 22 Park Street, Newbury, Berkshire, RG14 1EA
Telephone: +44 (0)1635 520 300
Fax: +44 (0)1635 580 180
Medical Information e-mail: medicalinformation@orionpharma.com
Out of Hours Telephone: +44 (0)1635 520 300

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 10/01/2012
PIL Stalevo 50/12.5/200mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/01/2012 and displayed until Current
Reasons for adding or updating:
  • Introduction of new strength
Updated on 10/09/2010 and displayed until 10/01/2012
Reasons for adding or updating:
  • Change to side-effects
Updated on 12/07/2010 and displayed until 10/09/2010
Reasons for adding or updating:
  • Change to date of revision
Updated on 20/04/2010 and displayed until 12/07/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 16/09/2009 and displayed until 20/04/2010
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 17/04/2009 and displayed until 16/09/2009
Reasons for adding or updating:
  • PIL Retired combination of strengths
Updated on 05/02/2009 and displayed until 17/04/2009
Reasons for adding or updating:
  • Individual presentations superseded by joint PIL
  • Joint PIL superseded by PILs for individual presentations
Updated on 28/09/2007 and displayed until 05/02/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Introduction of new pack
  • Change to MA holder contact details
Updated on 20/02/2007 and displayed until 28/09/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 01/06/2006 and displayed until 20/02/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 09/08/2004 and displayed until 01/06/2006
Reasons for adding or updating:
  • Change to Further Information section
Updated on 17/02/2004 and displayed until 09/08/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  entacapone
  levodopa
  carbidopa